Medigen Vaccine Biologics Corp Sustainability Reports
Medigen Vaccine Biologics Corp. develops, designs, and manufactures cell culture vaccines and biological agents. Its products include vaccines for Enterovirus A71, influenza, and COVID-19.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG009PX9G69
1 reports from 2024 to 2024
Company Profile
Medigen Vaccine Biologics Corp. develops, designs, and manufactures cell culture vaccines and biological agents. Its products include vaccines for Enterovirus A71, influenza, and COVID-19.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
